Unknown

Dataset Information

0

All-trans retinoic acid enhances, and a pan-RAR antagonist counteracts, the stem cell promoting activity of EVI1 in acute myeloid leukemia.


ABSTRACT: Ecotropic virus integration site 1 (EVI1), whose overexpression characterizes a particularly aggressive subtype of acute myeloid leukemia (AML), enhanced anti-leukemic activities of all-trans retinoic acid (atRA) in cell lines and patient samples. However, the drivers of leukemia formation, therapy resistance, and relapse are leukemic stem cells (LSCs), whose properties were hardly reflected in these experimental setups. The present study was designed to address the effects of, and interactions between, EVI1 and retinoids in AML LSCs. We report that Evi1 reduced the maturation of leukemic cells and promoted the abundance, quiescence, and activity of LSCs in an MLL-AF9-driven mouse model of AML. atRA further augmented these effects in an Evi1 dependent manner. EVI1 also strongly enhanced atRA regulated gene transcription in LSC enriched cells. One of their jointly regulated targets, Notch4, was an important mediator of their effects on leukemic stemness. In vitro exposure of leukemic cells to a pan-RAR antagonist caused effects opposite to those of atRA. In vivo antagonist treatment delayed leukemogenesis and reduced LSC abundance, quiescence, and activity in Evi1high AML. Key results were confirmed in human myeloid cell lines retaining some stem cell characteristics as well as in primary human AML samples. In summary, our study is the first to report the importance of EVI1 for key properties of AML LSCs. Furthermore, it shows that atRA enhances, and a pan-RAR antagonist counteracts, the effects of EVI1 on AML stemness, thus raising the possibility of using RAR antagonists in the therapy of EVI1high AML.

SUBMITTER: Nguyen CH 

PROVIDER: S-EPMC6904467 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

All-trans retinoic acid enhances, and a pan-RAR antagonist counteracts, the stem cell promoting activity of EVI1 in acute myeloid leukemia.

Nguyen Chi Huu CH   Bauer Katharina K   Hackl Hubert H   Schlerka Angela A   Koller Elisabeth E   Hladik Anastasiya A   Stoiber Dagmar D   Zuber Johannes J   Staber Philipp B PB   Hoelbl-Kovacic Andrea A   Purton Louise E LE   Grebien Florian F   Wieser Rotraud R  

Cell death & disease 20191210 12


Ecotropic virus integration site 1 (EVI1), whose overexpression characterizes a particularly aggressive subtype of acute myeloid leukemia (AML), enhanced anti-leukemic activities of all-trans retinoic acid (atRA) in cell lines and patient samples. However, the drivers of leukemia formation, therapy resistance, and relapse are leukemic stem cells (LSCs), whose properties were hardly reflected in these experimental setups. The present study was designed to address the effects of, and interactions  ...[more]

Similar Datasets

2019-12-13 | GSE123255 | GEO
| PRJNA507971 | ENA
| S-EPMC4613657 | biostudies-literature
| S-EPMC7600968 | biostudies-literature
2015-03-13 | GSE66837 | GEO
2015-03-13 | GSE66854 | GEO
| S-EPMC5514891 | biostudies-other
| S-EPMC4520659 | biostudies-literature
| S-EPMC7456978 | biostudies-literature
| S-EPMC6066298 | biostudies-literature